Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMMO: Oral Misoprostol vs IV Oxytocin for PROM Induction
NCT04478942Phase 1Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Oct 2020
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of misoprostol in premature rupture of membranes (PROM) (2 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Time from initial medication administration to vaginal delivery up to 72 hours. Started Oct 2020; status: completed.
02
Drugs
misoprostol
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT04478942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478942.